NovaBay Pharmaceuticals, Inc. (NBY) |
| 1.4699 -0.48 (-24.62%) 05-22 12:37 |
| Open: | 1.4699 |
| High: | 1.4699 |
| Low: | 1.4699 |
| Volume: | 86,826 |
| Market Cap: | 39(M) |
| PE Ratio: | -0.05 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 1.90 |
| Resistance 1: | 1.63 |
| Pivot price: | 1.50 |
| Support 1: | 1.20 |
| Support 2: | 1.00 |
| 52w High: | 99.75 |
| 52w Low: | 1.11 |
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Mon, 30 Mar 2026
NovaBay Pharmaceuticals Announces Corporate Name Change to Stablecoin Development Corporation - VisionMonday.com
Mon, 23 Mar 2026
NovaBay Pharmaceutical (NBY) pivoting to crypto - CoinDesk
Mon, 23 Mar 2026
Biotech stock NovaBay jumps 19% amid pivot, rebrand to Stablecoin Development Corporation - The Block
Fri, 20 Feb 2026
NovaBay Pharmaceuticals (NBY) completes 1-for-5 reverse stock split - Stock Titan
Thu, 12 Feb 2026
NovaBay Pharmaceuticals Announces 1-for-5 Reverse Stock Split - TradingView
Tue, 20 Jan 2026
NovaBay Pharmaceuticals stock falls after $100 million ATM offering - Investing.com
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |